Conserved protein targets for developing pan-coronavirus drugs based on sequence and 3D structure similarity analyses
文献类型:期刊论文
作者 | Ma, Minfei1,2; Yang, Yanqing1,2; Wu, Leyun1,2; Zhou, Liping1,2; Shi, Yulong1,2; Han, Jiaxin1,3; Xu, Zhijian1,2![]() ![]() |
刊名 | COMPUTERS IN BIOLOGY AND MEDICINE
![]() |
出版日期 | 2022-06 |
卷号 | 145页码:105455 |
关键词 | Pharmaceutical informatics Drug design Target discovery Medicinal chemistry Broad-spectrum drugs |
ISSN号 | 0010-4825 |
DOI | 10.1016/j.compbiomed.2022.105455 |
文献子类 | Article |
英文摘要 | There are 7 known human pathogenic coronaviruses, which are HCoV-229E, HCoV-OC43, HCoV-NL63, HCoVHKU1, MERS-CoV, SARS-CoV and SARS-CoV-2. While SARS-CoV-2 is currently caused a severe epidemic, experts believe that new pathogenic coronavirus would emerge in the future. Therefore, developing broad-spectrum anticoronavirus drugs is of great significance. In this study, we performed protein sequence and three-dimensional structure analyses for all the 20 virus-encoded proteins across all the 7 coronaviruses, with the purpose to identify highly conserved proteins and binding sites for developing pan-coronavirus drugs. We found that nsp5, nsp10, nsp12, nsp13, nsp14, and nsp16 are highly conserved both in protein sequences (with average identity percentage higher than 52%, average amino acid conservation scores higher than 5.2) and binding pockets (with average amino acid conservation scores higher than 5.8). We also performed the similarity comparison between these 6 proteins and all the human proteins, and found that all the 6 proteins have similarity less than 25%, indicating that the drugs targeting the 6 proteins should have little interference of human protein function. Accordingly, we suggest that nsp5, nsp10, nsp12, nsp13, nsp14, and nsp16 are potential targets for pancoronavirus drug development. |
WOS关键词 | ACCURATE DOCKING ; GLIDE ; TOOLS |
WOS研究方向 | Life Sciences & Biomedicine - Other Topics ; Computer Science ; Engineering ; Mathematical & Computational Biology |
语种 | 英语 |
WOS记录号 | WOS:000821011100004 |
出版者 | PERGAMON-ELSEVIER SCIENCE LTD |
源URL | [http://119.78.100.183/handle/2S10ELR8/309356] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Xu, Zhijian; Zhu, Weiliang |
作者单位 | 1.Chinese Acad Sci, Drug Discovery & Design Ctr, Stake Key Lab Drug Res, CAS Key Lab Receptor Res,Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 2.Univ Chinese Acad Sci, Sch Pharm, Beijing 100049, Peoples R China; 3.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210046, Peoples R China |
推荐引用方式 GB/T 7714 | Ma, Minfei,Yang, Yanqing,Wu, Leyun,et al. Conserved protein targets for developing pan-coronavirus drugs based on sequence and 3D structure similarity analyses[J]. COMPUTERS IN BIOLOGY AND MEDICINE,2022,145:105455. |
APA | Ma, Minfei.,Yang, Yanqing.,Wu, Leyun.,Zhou, Liping.,Shi, Yulong.,...&Zhu, Weiliang.(2022).Conserved protein targets for developing pan-coronavirus drugs based on sequence and 3D structure similarity analyses.COMPUTERS IN BIOLOGY AND MEDICINE,145,105455. |
MLA | Ma, Minfei,et al."Conserved protein targets for developing pan-coronavirus drugs based on sequence and 3D structure similarity analyses".COMPUTERS IN BIOLOGY AND MEDICINE 145(2022):105455. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。